Synergy Pharmaceuticals Inc fka SGYPQ

[iandy]

>The stock has seen a count of 6 insider trades in the past 3 months. These transactions include 6 sell trades and 0 buy activities. Furthermore, over the past 12 months, insider traded the stock on 6 occasions. In 6 instances, an employee was a seller while the insider of the company was the buyer in just 0 times.<

http://voiceregistrar.com/2016/11/09/insider-trading-activity-in-synergy-pharmaceuticals-inc-nasdaqsgyp/

In any event, today's news indicates plecanatide is pretty much a lock for approval.

>The late-cycle review meeting with the FDA was completed and no significant issues were identified. The FDA previously informed us that there are no plans at this time for an advisory committee meeting in connection with the review of the plecanatide NDA in CIC.<

https://www.google.com/amp/www.smarteranalyst.com/2016/11/09/stock-update-nasdaqsgyp-synergy-pharmaceuticals-inc-announces-3q16-results-business-update/amp/?client=safari

I am expecting the buyout for $15 will be announced tomorrow - J/K